L’anticorps anti-BMPR1A Monoclonal Souris est utilisé pour la détection de BMPR1A dans des échantillons de Humain. Il a été validé pour WB, ELISA, IHC et FACS.
BMPR1A
Reactivité: Humain, Souris, Rat
WB, ELISA, IHC, IF, ICC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Buffer
PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Antigène
BMPR1A
(Bone Morphogenetic Protein Receptor 1A (BMPR1A))
Autre désignation
BMPR1A
Sujet
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2.These receptors are also closely related to the activin receptors, ACVR1 and ACVR2.The ligands of these receptors are members of the TGF-beta superfamily.TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD.Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.